INVO FertilityIVF -2.59%35 14-Day RSI is 39.42 as of Jul. 10, 2026. GuruFocus rates IVF with a GF Score™ of 35/100 and a GF Value™ of $134.71 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 868 Medical Devices & Instruments companies, INVO Fertility ranks better than 73.04% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-10), INVO Fertility's 14-Day RSI is 39.42.
The industry rank for INVO Fertility's 14-Day RSI or its related term are showing as below:
IVF's 14-Day RSI is ranked better than 73.04% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 47.05
vs IVF: 39.42
INVO Fertility (NAS:IVF) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
INVO Fertility 14-Day RSI Related Terms
IVF vs RMSL, ADMT, USAQ: 14-Day RSI Comparison
For the Medical Devices subindustry, INVO Fertility's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
INVO Fertility 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, INVO Fertility's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where INVO Fertility's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INVO Fertility (IVF) has a 14-Day RSI of 39.42 as of Jul. 10, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on INVO Fertility and its competitors. According to the industry distribution chart, INVO Fertility ranks #234 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 27%.
Is INVO Fertility's 14-Day RSI too high?
INVO Fertility's current 14-Day RSI is 39.42. The Medical Devices & Instruments industry median 14-Day RSI is 47.05. INVO Fertility's value of 39.42 is 16.2% below this industry median. Based on the distribution chart, INVO Fertility ranks #234 out of 868 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, INVO Fertility has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does INVO Fertility's 14-Day RSI compare to RMSL and ADMT?
According to the Medical Devices & Instruments industry distribution chart, INVO Fertility ranks #234 out of 868 companies for 14-Day RSI. This puts INVO Fertility in the upper half of its industry. The industry median 14-Day RSI is 47.05. INVO Fertility's value of 39.42 is 16.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 47.05, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. INVO Fertility's current 14-Day RSI of 39.42 is 16.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on INVO Fertility and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 47.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. INVO Fertility's current 14-Day RSI is 39.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is INVO Fertility stock overvalued right now?
Based on GuruFocus' analysis, INVO Fertility (IVF) is currently considered Possible Value Trap. The stock's GF Value™ is $134.71, compared to a current price of $1.13 — trading 99.2% below its estimated fair value. The current 14-Day RSI is 39.42 and 16.2% below the Medical Devices & Instruments industry median of 47.05. INVO Fertility's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For INVO Fertility (IVF), the current 14-Day RSI is 39.42 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is INVO Fertility (IVF) Overvalued in 2026?
Based on GuruFocus' analysis, INVO Fertility stock appears to be undervalued.
The current stock price of $1.13 is trading 99.2% below its estimated GF Value™ of $134.71.
GuruFocus considers INVO Fertility to be Possible Value Trap.
Key valuation signals for IVF:
14-Day RSI: 39.42
GF Value™: $134.71 vs. price of $1.13 (99.2% below fair value)
Industry Position: 16.2% below the Medical Devices & Instruments median (#234 of 868)
No single metric tells the full story. See the IVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
35GF Score
Get the complete analysis for IVF
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IVF has been successfully added to your 